中华结核和呼吸杂志
中華結覈和呼吸雜誌
중화결핵화호흡잡지
Chinese Journal of Tuberculosis and Respiratory Diseases
2011年
4期
288-293
,共6页
黄东亚%刘军%吴晓燕%刘火根%吴爱萍%蒋大伟%杨毅%邱海波
黃東亞%劉軍%吳曉燕%劉火根%吳愛萍%蔣大偉%楊毅%邱海波
황동아%류군%오효연%류화근%오애평%장대위%양의%구해파
呼吸,人工%呼吸窘迫综合征,成人%膈
呼吸,人工%呼吸窘迫綜閤徵,成人%膈
호흡,인공%호흡군박종합정,성인%격
Respiration,artificial%Respiratory distress syndrome,adult%Diaphragm
目的 探讨神经调节辅助通气(NAVA)对ARDS呼吸机相关性膈肌功能障碍(VIDD)的预防作用.方法 将20只成年新西兰大白兔按随机数字表法分为对照组、容量控制通气组(VC组)、压力支持通气组(PSV组)和NAVA通气组(NAVA组),每组5只.VC、PSV及NAVA组在机械通气4 h后取膈肌标本,对照组麻醉后立即取膈肌标本.测定各组膈肌中丙二醛、超氧化物歧化酶(SOD)以及还原型谷胱甘肽(GSH)含量,观察各组膈肌纤维病理结构的改变.结果 (1)丙二醛:NAVA组膈肌中丙二醛含量为(0.28±0.19)nmol/mg,与对照组的(0.15±0.06)nmol/mg、PSV组的(0.30±0.11)nmol/mg比较,差异无统计学意义(F=2.730,P>0.05);VC组膈肌中丙二醛含量为(0.40±0.16)nmol/mg,明显高于对照组(P<0.05).(2)SOD:NAVA组膈肌中SOD含量为(94±9)U/mg,与对照组的(111±12)U/mg、PSV组的(93±4)U/mg比较,差异无统计学意义(F=4.422,P>0.05);VC组膈肌中SOD含量为(80±21)U/mg,明显低于对照组(P<0.05).(3)GSH:NAVA组膈肌中丙二醛含量为(5.6±1.0)mg/g,与对照组的(5.3±1.0)mg/g、PSV组的(4.5±1.2)mg/g比较,差异无统计学意义(F=3.001,P>0.05);VC组膈肌中GSH含量为(3.3±1.7)mg/g,明显低于对照组(P<0.05).(4)光镜观察:VC组出现肌纤维变性、坏死,部分肌纤维萎缩;NAVA、PSV组以及对照组肌纤维形态基本正常.(5)电镜观察:VC组肌原纤维断裂,线粒体肿胀;NAVA组、PSV组以及对照组超微结构无明显异常.(6)膈肌纤维横截面积:NAVA组平均肌纤维横截面积(像素)为2573±278,与对照组的3070+175、PSV组的2508±670比较,差异无统计学意义(F=1.775,P>0.05);VC组Ⅱ型肌纤维横截面积为2210±971,明显低于对照组的3477±187(P<0.05).结论 与控制通气相比较,NAVA可减轻ARDS膈肌氧化应激、膈肌萎缩和膈肌结构损伤,NAVA较控制通气更能预防VIDD.
目的 探討神經調節輔助通氣(NAVA)對ARDS呼吸機相關性膈肌功能障礙(VIDD)的預防作用.方法 將20隻成年新西蘭大白兔按隨機數字錶法分為對照組、容量控製通氣組(VC組)、壓力支持通氣組(PSV組)和NAVA通氣組(NAVA組),每組5隻.VC、PSV及NAVA組在機械通氣4 h後取膈肌標本,對照組痳醉後立即取膈肌標本.測定各組膈肌中丙二醛、超氧化物歧化酶(SOD)以及還原型穀胱甘肽(GSH)含量,觀察各組膈肌纖維病理結構的改變.結果 (1)丙二醛:NAVA組膈肌中丙二醛含量為(0.28±0.19)nmol/mg,與對照組的(0.15±0.06)nmol/mg、PSV組的(0.30±0.11)nmol/mg比較,差異無統計學意義(F=2.730,P>0.05);VC組膈肌中丙二醛含量為(0.40±0.16)nmol/mg,明顯高于對照組(P<0.05).(2)SOD:NAVA組膈肌中SOD含量為(94±9)U/mg,與對照組的(111±12)U/mg、PSV組的(93±4)U/mg比較,差異無統計學意義(F=4.422,P>0.05);VC組膈肌中SOD含量為(80±21)U/mg,明顯低于對照組(P<0.05).(3)GSH:NAVA組膈肌中丙二醛含量為(5.6±1.0)mg/g,與對照組的(5.3±1.0)mg/g、PSV組的(4.5±1.2)mg/g比較,差異無統計學意義(F=3.001,P>0.05);VC組膈肌中GSH含量為(3.3±1.7)mg/g,明顯低于對照組(P<0.05).(4)光鏡觀察:VC組齣現肌纖維變性、壞死,部分肌纖維萎縮;NAVA、PSV組以及對照組肌纖維形態基本正常.(5)電鏡觀察:VC組肌原纖維斷裂,線粒體腫脹;NAVA組、PSV組以及對照組超微結構無明顯異常.(6)膈肌纖維橫截麵積:NAVA組平均肌纖維橫截麵積(像素)為2573±278,與對照組的3070+175、PSV組的2508±670比較,差異無統計學意義(F=1.775,P>0.05);VC組Ⅱ型肌纖維橫截麵積為2210±971,明顯低于對照組的3477±187(P<0.05).結論 與控製通氣相比較,NAVA可減輕ARDS膈肌氧化應激、膈肌萎縮和膈肌結構損傷,NAVA較控製通氣更能預防VIDD.
목적 탐토신경조절보조통기(NAVA)대ARDS호흡궤상관성격기공능장애(VIDD)적예방작용.방법 장20지성년신서란대백토안수궤수자표법분위대조조、용량공제통기조(VC조)、압력지지통기조(PSV조)화NAVA통기조(NAVA조),매조5지.VC、PSV급NAVA조재궤계통기4 h후취격기표본,대조조마취후립즉취격기표본.측정각조격기중병이철、초양화물기화매(SOD)이급환원형곡광감태(GSH)함량,관찰각조격기섬유병리결구적개변.결과 (1)병이철:NAVA조격기중병이철함량위(0.28±0.19)nmol/mg,여대조조적(0.15±0.06)nmol/mg、PSV조적(0.30±0.11)nmol/mg비교,차이무통계학의의(F=2.730,P>0.05);VC조격기중병이철함량위(0.40±0.16)nmol/mg,명현고우대조조(P<0.05).(2)SOD:NAVA조격기중SOD함량위(94±9)U/mg,여대조조적(111±12)U/mg、PSV조적(93±4)U/mg비교,차이무통계학의의(F=4.422,P>0.05);VC조격기중SOD함량위(80±21)U/mg,명현저우대조조(P<0.05).(3)GSH:NAVA조격기중병이철함량위(5.6±1.0)mg/g,여대조조적(5.3±1.0)mg/g、PSV조적(4.5±1.2)mg/g비교,차이무통계학의의(F=3.001,P>0.05);VC조격기중GSH함량위(3.3±1.7)mg/g,명현저우대조조(P<0.05).(4)광경관찰:VC조출현기섬유변성、배사,부분기섬유위축;NAVA、PSV조이급대조조기섬유형태기본정상.(5)전경관찰:VC조기원섬유단렬,선립체종창;NAVA조、PSV조이급대조조초미결구무명현이상.(6)격기섬유횡절면적:NAVA조평균기섬유횡절면적(상소)위2573±278,여대조조적3070+175、PSV조적2508±670비교,차이무통계학의의(F=1.775,P>0.05);VC조Ⅱ형기섬유횡절면적위2210±971,명현저우대조조적3477±187(P<0.05).결론 여공제통기상비교,NAVA가감경ARDS격기양화응격、격기위축화격기결구손상,NAVA교공제통기경능예방VIDD.
Objective To evaluate the effect of neurally adjusted ventilatory assist (NAVA) on prevention of ventilator-induced diaphragmatic dysfunction (VIDD) in ARDS rabbits.Methods Twenty New Zealand white rabbits were randomly divided into 4 groups: ( 1 ) control group ( n = 5 ); ( 2 ) Volume control (VC) group ( n = 5 ); ( 3 ) Pressure support ( PSV ) group ( n = 5 ); (4) NAVA group ( n = 5 ).In VC, PSV and NAVA groups, the rabbits were killed and the diaphragm was removed after 4 hours of ventilation.Animals in the control group were not mechanically ventilated, and the diaphragm was also removed immediately after anesthetizing.In all rabbits, malondialdehyde ( MDA), superoxide disrmutase (SOD) and glutathione(GSH) of diaphragm were measured.Structure of diaphragm was observed by light microscope, electron microscope, constituent ratio and mean cross-sectional area (CSA) of diaphragm fiber.Results (1)MDA: Compared with the control [(0.15 ±0.06)nmol/mg], PSV group[(0.30 ±0.11)nmol/mg], there was no significant difference in MDA of diaphragm in NAVA group [( 0.28 ± 0.19 )nmol/mg] (F = 2.730, P > 0.05).MDA in VC group [(0.40 ±0.16)nmol/mg] was significantly higher than the control group (P<0.05).(2) SOD: Compared with control [( 111 ± 12) U/mg], PSV group [(93 ± 4) U/mg], there was no significant difference in SOD of diaphragm in NAVA group [( 94 ± 9 )U/mg] (F=4.422,P >0.05).SOD in VC group [(80 ±21 )U/mg] was significantly lower than the control group(P <0.05).(3)GSH: Compared with control [(5.3 ± 1.0)mg/g] and PSV group [(4.5 ±1.2)mg/g], there was no significant difference in GSH of diaphragm in NAVA group [(5.6 ± 1.0) mg/g](F =3.001 ,P > 0.05 ).GSH in VC group [(3.3 ± 1.7)mg/g] is significantly lower than control and NAVA groups ( P < 0.05 ).( 4 ) Light microscope: In VC group, many changes were observed in the muscle, such as myofibrosis, necrosis, and some of muscle fibers became atrophy, but these were no obvious changes of pathological structure in control, PSV or NAVA groups.(5)Electron microscope: In control, PSV and NAVA groups, the ultrastructure of diaphragm was normal Different from the above 3 groups, some abnormal ultrastructure was observed in VC group, including disrupted myofibrils, swollen mitochondria.(6)CSA of diaphragm fiber: Compared with control and PSV group, there was no significant difference in CSA of diaphragm fiber in NAVA group ( P > 0.05 ); The CSA of type Ⅱ fibers in VC group was markedly lower than control group ( P < 0.05 ) .Conclusions Compared with volume control ventilation, NAVA may mitigate diaphragmatic oxidative stress, atrophy and injury, and prevent VIDD better than VC.